Preclinical evaluation of the engineered stem cell chemokine stromal cell-derived factor 1α analog in a translational ovine myocardial infarction model.
about
An innovative biologic system for photon-powered myocardium in the ischemic heart.Injectable microsphere gel progressively improves global ventricular function, regional contractile strain, and mitral regurgitation after myocardial infarction.Magnetic Resonance Imaging of Cardiac Strain Pattern Following Transplantation of Human Tissue Engineered Heart Muscles.Development of a new model for acute myocardial infarction in rabbitsInflammation as a therapeutic target in myocardial infarction: learning from past failures to meet future challenges.Aging Effects on Cardiac Progenitor Cell Physiology.Regenerative pharmacology: recent developments and future perspectives.Vascularization of three-dimensional engineered tissues for regenerative medicine applications.Injectable Bioengineered Hydrogel Therapy in the Treatment of Ischemic Cardiomyopathy.Overexpression of hypoxia-inducible factor 1 alpha improves immunomodulation by dental mesenchymal stem cells.Systemic redistribution of the intramyocardially injected mesenchymal stem cells by repeated remote ischaemic post-conditioning.Anti-inflammatory therapies in myocardial infarction: failures, hopes, and challenges.SDF 1-alpha Attenuates Myocardial Injury Without Altering the Direct Contribution of Circulating Cells.3D and 4D Bioprinting of the Myocardium: Current Approaches, Challenges, and Future Prospects.
P2860
Q33797866-4862800E-2109-4CE2-A212-CFB4ACB17E24Q35039708-D5B0EA42-70F4-4E4F-992F-42E42C4788B8Q37735801-E6C62A6F-1F8F-4E59-A7AD-43015D154CA9Q37740072-D09740CB-969F-4419-9D78-B54B2E18D717Q38560476-3625E746-42EC-4A4E-9FE9-8E26E5877817Q38596695-BFBC79D0-79F5-49A2-9C22-6CC034EABCE2Q38788701-48AA0499-F68E-483C-A7C9-42D61E684530Q38855056-3B263F5A-A2DD-43FB-9719-17ECF70679EBQ39197932-7F7471A2-62F8-4B9E-B806-F4BFA4847BB2Q42368076-5C915BC8-77C6-4F4C-932D-403B17E990E3Q47117835-FF437714-66C2-428F-87B9-B70945C28723Q48113765-D8F8B21F-0600-447D-817E-D6801DD04B3AQ52731083-54E6460E-8263-4FF6-9BB3-179932BAC8BAQ54975606-420063F7-EA59-4878-8D8C-65A3F8B40C0B
P2860
Preclinical evaluation of the engineered stem cell chemokine stromal cell-derived factor 1α analog in a translational ovine myocardial infarction model.
description
2013 nî lūn-bûn
@nan
2013 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
name
Preclinical evaluation of the ...... e myocardial infarction model.
@ast
Preclinical evaluation of the ...... e myocardial infarction model.
@en
Preclinical evaluation of the ...... e myocardial infarction model.
@nl
type
label
Preclinical evaluation of the ...... e myocardial infarction model.
@ast
Preclinical evaluation of the ...... e myocardial infarction model.
@en
Preclinical evaluation of the ...... e myocardial infarction model.
@nl
prefLabel
Preclinical evaluation of the ...... e myocardial infarction model.
@ast
Preclinical evaluation of the ...... e myocardial infarction model.
@en
Preclinical evaluation of the ...... e myocardial infarction model.
@nl
P2093
P2860
P1433
P1476
Preclinical evaluation of the ...... ne myocardial infarction model
@en
P2093
Alexander S Fairman
Andrew B Goldstone
Bryan B Edwards
George Hung
James J Pilla
Jay B Patel
Jeffrey E Cohen
Jeremy R McGarvey
John W Macarthur
Joseph H Gorman
P2860
P304
P356
10.1161/CIRCRESAHA.114.302884
P577
2013-12-23T00:00:00Z